Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

60.56 -0.82 (-1.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Earnings Preview For Hologic
Via Benzinga
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023
From Hologic, Inc.
Via Business Wire
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... 
Via FinancialNewsMedia
Cowen & Co. Maintains Outperform Rating for Hologic: Here's What You Need To Know
Via Benzinga
Earnings Outlook For Hologic
Via Benzinga
Where Hologic Stands With Analysts
Via Benzinga
Analyst Expectations for Hologic's Future
Via Benzinga
Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference
From Hologic, Inc.
Via Business Wire
Hologic “Making a World of Difference” Through Global Sustainability Impact
From Hologic, Inc.
Via Business Wire
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
Will Investors Notice Exciting Sign On Hologic's Chart?
Via Benzinga
7 Analysts Have This to Say About Hologic
Via Benzinga
Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent
From Hologic Inc.
Via Business Wire
Image-Guided Biopsy Market Is Expected to Reach at High CAGR of 5.49% by 2022-2029
[180 Pages Report] Image-Guided Biopsy Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.49 % during the forecast period... 
Via SBWire
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
Hologic Announces Financial Results for First Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
Medical Imaging Information Systems Market Share with Top Countries Data, Size, Global Analysis and Forecasts by Component by Type and Application
Medical Imaging Information Systems SWOT Analysis Including Key Players - Esaote, Fonar Corp, Fujifilm Corp, Fujifilm Sonosite, Ge Healthcare, Hitachi Medical Corp, Hologic, Mindray Medical... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
What's Going On With Hologic Shares Today?
Hologic, Inc. (NASDAQ: HOLX) shares are trading higher today after the company reported preliminary first-quarter revenue results. 
Via Benzinga
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Minicarm.com Expands Their Operations With Their New Mini C-Arm Refurbishment Center
Award-winning company expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center. 
Via Newswire.com
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
By Ernest Dela Aglanu, Benzinga 
Via News Direct
Topics Death
Exposures Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... 
Via TheNewswire.com
Topics Death
Exposures Death
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX< 
Via Benzinga
Stacey D. Stewart Elected to Hologic Board of Directors
From Hologic, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.